Research Article: Clinical and Economic Burden Associated with Disruptive Surgical Bleeding: A Retrospective Database Analysis
Abstract:
Bleeding, a common intra- and post-operative surgical complication, may range from mild to severe in both its intensity and impact. At the extreme, surgery-related bleeding increases mortality risk and has also been associated with increased use of high-intensity and expensive health-care services (eg, intensive care unit [ICU] admissions), longer operating times and hospital stays, elevated risk of a reoperation, and higher all-cause direct health-care costs.– A variety of hemostatic agents are routinely used to control bleeding during surgical procedures in hospitals in the United States; however, some patients experience disruptive bleeding despite the use of hemostats. A previous study by Corral et al documented an association of disruptive bleeding with higher mortality risk, as well as greater healthcare resource use and total hospital costs among patients who had received a hemostatic agent during one of eight surgical procedures deemed by surgeons to carry substantial risk of bleeding. However, the surgeries evaluated in that study were all performed via an open surgical approach and all in calendar year ; since that time, additional hemostatic agents have become available in the US and a systematic shift toward minimally invasive surgeries (MIS) has occurred.–
Introduction:
Bleeding, a common intra- and post-operative surgical complication, may range from mild to severe in both its intensity and impact. At the extreme, surgery-related bleeding increases mortality risk and has also been associated with increased use of high-intensity and expensive health-care services (eg, intensive care unit [ICU] admissions), longer operating times and hospital stays, elevated risk of a reoperation, and higher all-cause direct health-care costs. – A variety of hemostatic agents are routinely used to…
Read more